← Back to Search

Guided Meditation + Aromatherapy for Anxiety

N/A
Recruiting
Led By Jennifer Withall, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-15 minutes prior to injection, 5 minutes post-injection (day 1)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether guided meditation and aromatherapy can reduce anxiety in adult orthopedic patients who need joint injections. Participants will either listen to a calming voice, use a device that releases soothing smells, or receive standard care. The goal is to see which method helps patients feel less anxious.

Who is the study for?
This trial is for adult English-speaking patients at NYU Langone's specific clinics, who are scheduled to receive an intra-articular injection and have consented to that treatment. It aims to help those experiencing anxiety or pain associated with these injections.
What is being tested?
The study examines if guided meditation alone (Group A) or combined with aromatherapy using an Elequil Aromatab (Group B) before the injection can reduce anxiety compared to standard nursing care (Control Group C). Participants are randomly placed into one of these three groups.
What are the potential side effects?
Since this trial involves non-invasive interventions like guided meditation and aromatherapy, side effects may be minimal but could include potential allergic reactions to the aromatherapy product.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-15 minutes prior to injection, 5 minutes post-injection (day 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-15 minutes prior to injection, 5 minutes post-injection (day 1) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Blood Pressure
Change in Heart Rate
Change in Pain Score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental Group BExperimental Treatment2 Interventions
Participants in Group B will receive an Elequil Aromatab and the same guided meditation delivered to Group A prior to receiving the intra-articular injection.
Group II: Experimental Group AExperimental Treatment1 Intervention
Participants in Group A will receive a guided meditation prior to receiving the intra-articular injection.
Group III: ControlActive Control1 Intervention
Participants in the control arm will receive the current standard of nursing care for treating anxiety prior to receiving the intra-articular injection (emotional support, distraction, and/or therapeutic touch as necessary).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Guided Meditation
2021
N/A
~400

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Guided meditation works by promoting relaxation and reducing stress through focused attention and mindfulness, which can decrease sympathetic nervous system activity and lower cortisol levels. Elequil Aromatab, an aromatherapy intervention, uses olfactory stimulation to influence the limbic system, which is involved in emotion regulation and stress response. These mechanisms are crucial for anxiety patients as they provide non-pharmacological options to manage anxiety symptoms, potentially reducing the need for medication and its associated side effects. By leveraging the body's natural relaxation responses, these treatments can offer immediate and accessible relief from anxiety.
The effects of inhalation aromatherapy on anxiety in patients with myocardial infarction: a randomized clinical trial.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,317 Total Patients Enrolled
Jennifer Withall, PhDPrincipal InvestigatorNYU Langone Health
Meredith D'AnnaPrincipal InvestigatorNYU Langone Health

Media Library

Experimental Group A Clinical Trial Eligibility Overview. Trial Name: NCT05832983 — N/A
Botox Research Study Groups: Control, Experimental Group A, Experimental Group B
Botox Clinical Trial 2023: Experimental Group A Highlights & Side Effects. Trial Name: NCT05832983 — N/A
Experimental Group A 2023 Treatment Timeline for Medical Study. Trial Name: NCT05832983 — N/A
~16 spots leftby Jul 2025